Medications for Operative Surgical Procedures

14 results
  • Seton Pharmaceuticals, LLC
    Usage: Aminocaproic acid tablets enhance hemostasis in cases where fibrinolysis causes bleeding, particularly after heart surgery, in hematological disorders, abruptio placentae, hepatic cirrhosis, and certain cancers. It also addresses excessive urinary bleeding following surgical or nonsurgical procedures in the genitourinary system.
  • Optimus Pharma Private Limited
    Usage: Aminocaproic acid tablets enhance hemostasis in bleeding due to fibrinolysis, particularly in surgical complications, hematological disorders, abruptio placentae, hepatic cirrhosis, and certain cancers. They also address excessive urinary tract fibrinolytic bleeding post-surgery or due to genitourinary diseases. Emergency measures may be needed in severe cases.
  • Biocon Pharma Inc.
    Usage: Aminocaproic acid is indicated for enhancing hemostasis in scenarios where fibrinolysis causes bleeding, particularly after heart surgery, in hematological disorders, hepatic cirrhosis, and related neoplastic diseases. It is also used for excessive urinary tract bleeding following surgical or nonsurgical interventions.
  • airis PHARMA Private Limited
    Usage: Aminocaproic acid oral solution is indicated for enhancing hemostasis in cases of fibrinolytic bleeding, particularly post-heart surgery, in hematological disorders, during acute abruptio placentae, in hepatic cirrhosis, and certain cancers. It can also address excessive urinary tract bleeding linked to surgical or nonsurgical hematuria.
  • Wilshire Pharmaceuticals, Inc.
    Usage: Dexmedetomidine hydrochloride in 0.9% sodium chloride is indicated for sedation of intubated and mechanically ventilated adults in intensive care, as well as for non-intubated adults before and during surgical procedures. Continuous infusion should not exceed 24 hours.
  • Piramal Critical Care Inc
    Usage: Dexmedetomidine hydrochloride in 0.9% sodium chloride injection is indicated for sedation in intubated, mechanically ventilated patients in intensive care and for procedural sedation in non-intubated patients before or during surgical and other procedures. It should be administered via continuous infusion, not exceeding 24 hours.
  • Medical Purchasing Solutions, LLC
    Usage: Dexmedetomidine hydrochloride injection is indicated for sedation in initially intubated and mechanically ventilated patients in intensive care, as well as for procedural sedation in non-intubated patients during surgical and other procedures. Continuous infusion should not exceed 24 hours.
  • ENDO USA, Inc.
    Usage: Dexmedetomidine hydrochloride injection is indicated for sedation of initially intubated and mechanically ventilated adults in intensive care settings and for non-intubated adults undergoing surgical or other procedures. It may be used continuously for up to 24 hours. Pediatric use information is not included.
  • Sandoz Inc.
    Usage: Dexmedetomidine hydrochloride in 0.9% sodium chloride is indicated for sedation of intubated, mechanically ventilated adult patients in intensive care, and for non-intubated adults during surgical and other procedures. It can be continuously infused without interruption prior to extubation.
  • Henry Schein, Inc.
    Usage: Midazolam injection is indicated for preoperative sedation, anxiety relief, and amnesia, as well as sedation during various diagnostic and therapeutic procedures. It is also used for induction of general anesthesia and continuous infusion for sedation in intubated, mechanically ventilated patients in critical care.